Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs

Cell Biology International

Volumn 32, Issue 2, 2008, Pages 188-197

  Fan, Yan ying ^a   Yang, Bin yan ^a   Wu, Chang you ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cytokine production; Cytotoxicity; Natural killer cells; Phenotype; Proliferation

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CELL ADHESION MOLECULE; CELL MARKER; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; PERFORIN;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CYTOLYSIS; FEMALE; HUMAN; HUMAN CELL; MALE; MEMORY CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE;

ADULT; ANTIGENS, CD56; BIOLOGICAL MARKERS; CELL PROLIFERATION; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, IGG;

EID: 39549106663     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.08.025     Document Type: Article

References (46)

1. dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scand J Immunol 62 (2005) 498-506
2. Baume D.M., Robertson M.J., Levine H., Manley T.J., Schow P.W., and Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol 22 (1992) 1-6
3. + T cell differentiation in peripheral blood. Eur J Immunol 35 (2005) 2608-2616
4. Bryceson Y.T., March M.E., Ljunggren H., and Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214 (2006) 73-91
5. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
6. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., and Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 171 (1990) 1509-1526
7. bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol 27 (1997) 354-360
8. Cooper M.A., Fehniger T.A., and Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 22 (2001) 633-640
9. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A. NK cell and DC interactions. Trends Immunol 25 (2004) 47-52
10. Esplugues E., Sancho D., Vega-Ramos J., Martinez C., Syrbe U., Hamann A., et al. Enhanced antitumor immunity in mice deficient in CD69. J Exp Med 197 (2003) 1093-1106
11. Esplugues E., Vega-Ramos J., Cartoixa D., Vazquez B.N., Salaet I., Engel P., et al. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy. Blood 105 (2005) 4399-4406
12. Fauci A.S., Mavilio D., and Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5 (2005) 835-843
13. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162 (1999) 4511-4520
14. bright natural killer cells. Immunity 22 (2005) 295-304
15. dim natural killer cell subsets. J Immunol 161 (1998) 400-408
16. Hayakawa Y., and Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176 (2006) 1517-1524
17. Herberman R.B., and Ortaldo J.R. Natural killer cells: their role in defence against disease. Science 214 (1981) 24
18. + mononuclear blood cells. J Clin Immunol 10 (1990) 311-320
19. Johansson S., Berg L., Hall H., and Hoglund P. NK cells: elusive players in autoimmunity. Trends Immunol 26 (2005) 613-618
20. Jonges L.E., Albertsson P., van Vlierberghe R.L., Ensink N.G., Johansson B.R., van de Velde C.J., et al. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand J Immunol 53 (2001) 103-110
21. Kelly J.M., Darcy P.K., Markby J.L., Godfrey D.I., Takeda K., Yagita H., et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3 (2002) 83-90
22. Kim H.P., Imbert J., and Leonard W.J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17 (2006) 349-366
23. Kyriakou D., Papadaki H.A., Sakellariou D., Eliopoulos A.G., Kapsimali V., and Eliopoulos G.D. Flow-cytometric analysis of peripheral blood lymphocytes in patients with chronic idiopathic neutropenia of adults. Ann Hematol 75 (1997) 103-110
24. Lanier L.L. On guard-activating NK cell receptors. Nat Immunol 2 (2001) 23-27
25. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
26. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 102 (2005) 2886-2891
27. Medvedev A.E., Johnsen A.C., Haux J., Steinkjer B., Egeberg K., Lynch D.H., et al. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 9 (1997) 394-404
28. Moretta L., Bottino C., Pende D., Mingari M.C., Biassoni R., and Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol 32 (2002) 1205-1211
29. Nagao F., Yabe T., Xu M., and Okumura K. Phenotypical and functional analyses of natural killer cells from low NK activity individuals among healthy and patient populations. Nat Immun 14 (1995) 225-233
30. Nagler A., Lanier L.L., Cwirla S., and Phillips J.H. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143 (1989) 3183-3191
31. Nolte M.A., Arens R., van Os R., van Oosterwijk M., Hooibrink B., van Lier R.A., et al. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol 6 (2005) 412-418
32. North J., Bakhsh I., Marden C., Pittman H., Addison E., Navarrete C., et al. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J Immunol 178 (2007) 85-94
33. O'Leary J.G., Goodarzi M., Drayton D.L., and von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7 (2006) 507-516
34. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
35. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
36. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22 (2004) 745-763
37. + natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78 (1996) 83-85
38. dim NK cells. Scand J Immunol 65 (2007) 126-138
39. Takeda K., Oshima H., Hayakawa Y., Akiba H., Atsuta M., Kobata T., et al. CD27-mediated activation of murine NK cells. J Immunol 164 (2000) 1741-1745
40. bright NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol 22 (2002) 176-183
41. + T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 34 (2004) 999-1010
42. Trapani J.A., and Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2 (2002) 735-747
43. Trinchieri G. Biology of natural killer cells. Adv Immunol 47 (1989) 187-376
44. - natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells. Eur J Immunol 34 (2004) 1715-1722
45. Yokoyama W.M., and Kim S. How do natural killer cells find self to achieve tolerance. Immunity 24 (2006) 249-257
46. Zhang C., Zhang J., and Tian Z. The regulatory effect of natural killer cells: do "NK-reg cells" exist?. Cell Mol Immunol 3 (2006) 241-254